Shares of UnitedHealth Group Incorporated (NYSE:UNH) bought by RBA Wealth Management LLC

RBA Wealth Management LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.3% in the second quarter, according to its most recent filing with the SEC. The fund owned 11,941 shares of the healthcare conglomerate’s stock after acquiring an additional 156 shares during the period. UnitedHealth Group comprises about 2.4% of RBA Wealth Management LLC’s portfolio, making the stock its 11th largest holding. RBA Wealth Management LLC’s holdings in UnitedHealth Group were worth $6,081,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of UNH. True Wealth Design LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at $31,000. Delos Wealth Advisors LLC boosted its holdings in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares during the last quarter. Bbjs Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the second quarter valued at $31,000. Signature Resources Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the medical conglomerate’s stock worth $32,000 after acquiring an additional 18 shares in the last quarter. Finally, Red Tortoise LLC boosted its holdings in shares of UnitedHealth Group by 45.1% in the first quarter. Red Tortoise LLC now owns 74 shares of the medical conglomerate’s stock worth $36,000 after acquiring an additional 23 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s shares.

UnitedHealth Group price performance

Shares of UnitedHealth Group stock traded up $3.17 during midday trading on Monday, reaching $580.85. 336,075 shares of the company traded hands, compared to its average volume of 4,203,520. The company has a fifty day moving average of $529.38 and a 200 day moving average of $507.42. The company has a quick ratio of 0.85, a current ratio of 0.88, and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $591.54. The company has a market cap of $536.37 billion, a PE ratio of 35.45, a price-to-earnings-growth ratio of 1.61 and a beta of 0.59.

UnitedHealth Group (NYSE:UNH – Get Free Report ) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping the consensus estimate of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. In the same period last year, the company earned $6.14 per share. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group announces dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, September 16. This represents an annualized dividend of $8.40 and a yield of 1.45%. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

Insider buying and selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed via this link. In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed via this link. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s shares.

Analyst upgrades and downgrades

UNH has been the subject of several analyst reports. Morgan Stanley upped their target price on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research report on Tuesday, July 23rd. Barclays boosted their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Wells Fargo & Company lifted their price target on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Finally, HSBC boosted their price objective on shares of UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. One investment analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and an average price target of $614.17, according to MarketBeat.com.

Get the latest stock analysis on UnitedHealth Group

About UnitedHealth Group

(Free report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment provides consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; health care coverage and health and wellness services for people age 50 and older that address their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits and hospital and clinic services, and health care products and services for state care programs for the economically disadvantaged, medically underserved, and those without funded health care coverage by employer.

Featured stories

Want to see what other hedge funds own UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Get daily news and ratings for UnitedHealth Group – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.